GuangYuYuan Chinese Herbal Medicine Co Ltd banner

GuangYuYuan Chinese Herbal Medicine Co Ltd
SSE:600771

Watchlist Manager
GuangYuYuan Chinese Herbal Medicine Co Ltd Logo
GuangYuYuan Chinese Herbal Medicine Co Ltd
SSE:600771
Watchlist
Price: 13.73 CNY 1.4% Market Closed
Market Cap: ¥6.7B

Wall St Price Targets

Price Targets Summary
GuangYuYuan Chinese Herbal Medicine Co Ltd

There are no price targets for GuangYuYuan Chinese Herbal Medicine Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
GuangYuYuan Chinese Herbal Medicine Co Ltd Competitors:
Price Targets

Revenue
Forecast

14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 6 years is 6%.

Gross Profit
Forecast

16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for GuangYuYuan Chinese Herbal Medicine Co Ltd

Operating Income
Forecast

N/A
Past Growth
-34% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
-34% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 9 years is -34%.

Pre-Tax Income
Forecast

-9% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
-9% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -9%. The projected CAGR for the next 6 years is 28%.

Net Income
Forecast

-12% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-12% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 6 years is 35%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GuangYuYuan Chinese Herbal Medicine Co Ltd's stock price target?
Not Available

GuangYuYuan Chinese Herbal Medicine Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for GuangYuYuan Chinese Herbal Medicine Co Ltd?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 6 years is 6%.

What is the Operating Income forecast for GuangYuYuan Chinese Herbal Medicine Co Ltd?
Projected CAGR
-34%

The compound annual growth rate for Operating Income over the next 9 years is -34%.

What is the Pre-Tax Income forecast for GuangYuYuan Chinese Herbal Medicine Co Ltd?
Projected CAGR
28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -9%. The projected CAGR for the next 6 years is 28%.

What is the Net Income forecast for GuangYuYuan Chinese Herbal Medicine Co Ltd?
Projected CAGR
35%

Over the last 13 years, the compound annual growth rate for Net Income has been -12%. The projected CAGR for the next 6 years is 35%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett